PandaOmics

✈ The latest from PandaOmics! Introducing PandaOmics Box. Transform the #research landscape, empowering researchers to excel in target identification, biomarker discovery and indication prioritization. Hear from Insilico Medicine's CEO, Alex Zhavoronkov to learn more about this new #drugdiscovery toolkit. Visit our website today: https://lnkd.in/dsviKa7e

💡 Attention Researchers: See how you can generate #researchpapers with pre-existing results, using the latest Science42: #DORA from Insilico Medicine. DORA makes performing multiple research tasks easier: from disease hypothesis, #targetdiscovery, #clinicaltrials analysis, and #bioinformatics analysis, all the way to drafting scientific articles. Continue learning here: https://lnkd.in/dEPshUTw

Excited to announce Petrina Kamya, Ph.D., Global Head of #AI Platforms at Insilico Medicine as part of the DDIF conference in Berlin. #Drugdevelopment #DDIF #GBXevents

Announcing PandaOmics Box: Transform the #research landscape, empowering researchers to excel in #targetidentification, biomarker discovery and indication prioritization. Top features include: -On-site deployment with advanced security protection -On-site deployment and eliminating external data transmission -Incorporates with Insilico Secure Application Platform (ISAP) to enable chip-level confidential computing, and offer multi-layered security protection. Superior Data Processing Power -The platform is designed to handle and analyze exceptionally large datasets efficiently, capable of processing over 1000 samples seamlessly. Head to https://bit.ly/46zgmGC for more information.

I am very happy to announce the publication of my opinion piece titled "Is Generative AI in Drug Discovery Overhyped?" in the journal many of us got to love over the years Genetic Engineering & Biotechnology News. There is no doubt that advances in generative AI are already transforming and will transform drug discovery but where are we now? Are there any industry benchmarks? Are analysts and journalists asking the right questions? I spent over a decade in this industry and saw several "AIDD Theranos" stories that the media and analysts ignored completely as in this industry the timelines are stretched beyond the span of analysts' memories. In this article I propose a set of questions for any AIDD company in the industry. And if I wore the investor's hat, I would seriously consider asking these questions. Have a look and let me know if there is anything I missed? Source: https://lnkd.in/gZw_fmqT

Hear the latest updates from #Pharma.AI, part of Insilico Medicine's latest #IMGAIA announcement. PandaOmics Box is now available: https://lnkd.in/dsviKa7e

According to Petrina Kamya, Ph.D. Kamya, PhD, global head of #AIplatforms, and vice president of Insilico Medicine, Science42: #DORA integrates multiple AI agents that leverage #LLMs, designed to streamline the process of drafting #academicpapers and other scientific documents including grant and patent applications, internal research summaries, IND applications, etc. It assists researchers in drafting these types of documents with proper referencing through engineered prompts, proprietary databases, and pre-designed content generation workflows, she added. “Often the most difficult step when it comes to writing is starting the process. Something that I experienced first-hand as a graduate student when I was tasked with writing numerous grants, papers, and reports,” said Kamya. “We developed Science42:DORA to help eliminate that debilitating barrier to writing scientific documents.” Read the full piece from Genetic Engineering & Biotechnology News! https://bit.ly/3YpnyDt

We are proud to announce Petrina Kamya, PhD, as she joins the AI Driven Drug Discovery Summit 2024 in Boston this November 12-14. To join her there, register now: https://bit.ly/3yjexRA #AIDDD

Take a deeper dive into the newest 🐼 PandaOmics Box today! https://lnkd.in/dsviKa7e #newrelease #research #diseasemodeling

Amazing to see senior industry journalists Brian K. Buntz of Drug Discovery Trends testing #Science42 #DORA - this is the first time anyone external to Insilico Medicine tested both DORA and #Precious3GPT. https://lnkd.in/gvXYx4vF